Loading clinical trials...
Loading clinical trials...
A randomized, double-blind, placebo-controlled phase III study evaluating the efficacy and safety of oral ICP-332 in subjects with moderate to severe atopic dermatitis
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Beijing InnoCare Pharma Tech Co., Ltd.
NCT07223697 · Atopic Dermatitis
NCT07217015 · Atopic Dermatitis
NCT07298395 · Atopic Dermatitis (AD)
NCT06116526 · Atopic Dermatitis
NCT07006792 · Atopic Dermatitis
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui
The Second Affiliated Hospital of Wannan Medical College
Wuhu, Anhui
Capital Medical University Affiliated Beijing Chaoyang Hospital
Beijing, Beijing Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions